Filter
777
Filtered Results: 777
Text search:
drug
or
vaccine
reaction
Featured
Recommendations
95
New Publications
223
Language
Document type
No document type
439
Guidelines
141
Studies & Reports
90
Manuals
40
Strategic & Response Plan
30
Fact sheets
14
Training Material
11
Situation Updates
5
Brochures
3
Infographics
3
Resource Platforms
1
Countries / Regions
India
41
Kenya
27
South Africa
25
Nigeria
22
Uganda
22
Ethiopia
21
Global
20
Western and Central Europe
20
Ghana
17
Tanzania
17
Nepal
15
Latin America and the Carribbean
14
Africa
11
Zambia
11
Sierra Leone
10
Malawi
10
Liberia
10
Bangladesh
9
Namibia
9
Myanmar / Burma
9
Rwanda
8
Zimbabwe
8
Eastern Europe
8
Lesotho
6
Senegal
6
Philippines
6
South–East Asia Region
6
Congo, Democratic Republic of
5
USA
4
Germany
4
Botswana
4
Burkina Faso
3
Cambodia
3
West and Central Africa
3
Western Pacific Region
3
Brazil
3
Ukraine
2
Cameroon
2
Haiti
2
Venezuela
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
South Sudan
2
Indonesia
2
Thailand
1
Mexico
1
Turkey
1
Gambia
1
Syria
1
Iran
1
Mozambique
1
Asia
1
Argentina
1
Lebanon
1
Papua New Guinea
1
Russia
1
Central African Republic
1
Angola
1
Somalia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
319
Clinical Guidelines
117
Public Health
36
Women & Child Health
28
Pharmacy & Technologies
17
Capacity Building
12
Key Resources
12
Toolboxes
TB
84
COVID-19
66
HIV
53
Pharmacy
46
Rapid Response
41
NTDs
33
Ebola
31
AMR
31
Caregiver
16
Refugee
15
Mental Health
11
Conflict
10
Natural Hazards
7
Cholera
7
Polio
7
NCDs
6
Zika
6
Planetary Health
5
Specific Hazards
4
Health Financing Toolbox
4
Global Health Education
3
Disability
1
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
National Guidelines for Antiretroviral Therapy
recommended
The guidelines presented in this document are designed to provide a useful resource for healthcare professionals involved in clinical case management. They were developed taking into consideration services provided at different levels within the health system and resources available. These guideline...
6th edition
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
